FundX Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FundX Investment Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,598	Closed	-$2.39M	–	48
2021 Q1	$2.39M	Buy	17,598 +1,634	+10%	+$245K	1.35%	18
2020 Q4	$2.25M	Buy	15,964 +356	+2%	+$45.6K	0.94%	19
2020 Q3	$1.74M	Buy	+15,608	New	+$1.75M	0.67%	21
2018 Q4	–	Sell	-23,150	Closed	-$2.22M	–	57
2018 Q3	$2.22M	Buy	23,150 +3,787	+20%	+$367K	1.22%	11
2018 Q2	$1.84M	Buy	19,363 +1,337	+7%	+$123K	0.91%	12
2018 Q1	$1.58M	Sell	18,026 -457	-2%	-$41.7K	0.83%	11
2017 Q4	$1.57M	Buy	18,483 +1,113	+6%	+$93.2K	0.79%	15
2017 Q3	$1.5M	Buy	+17,370	New	+$1.39M	0.63%	14
2013 Q4	–	Sell	-8,400	Closed	-$362K	–	31
2013 Q3	$362K	Sell	8,400 -15,000	-64%	-$608K	0.14%	21
2013 Q2	$813K	Buy	+23,400	New	+$822K	0.35%	18

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

FundX Investment Group's XBI Position: Q2 2021 in Review

FundX Investment Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 17,598 shares — an estimated $2.39M sold.

FundX Investment Group first reported a position in XBI in Q2 2013 and held it in 10 quarters. The position peaked at $2.39M in Q1 2021. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

FundX Investment Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
FundX Investment Group sold 17,598 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $2.39M.
FundX Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 10 quarters.
FundX Investment Group's State Street SPDR S&P Biotech ETF position peaked at $2.39M in Q1 2021.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on FundX Investment Group's 13F filing for Q2 2021, filed 27 Jul 2021.